OMED

OncoMed Pharmaceuticals, Inc.
OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

85 hedge funds and large institutions have $156M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 11 closing their positions.

Holders
85
Holders Change
-1
Holders Change %
-1.16%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
28
Reduced
25
Closed
11
Calls
$7.57M
Puts
$3.19M
Net Calls
+$4.38M
Net Calls Change
+$3.78M
Name Market Value Shares Shares
Change
Shares
Change %
MAM
76
Meeder Asset Management
Ohio
$16K 1,716 -1,259 -42%
CLOS
77
Compagnie Lombard Odier SCmA
Switzerland
$14K 1,500
US Bancorp
78
US Bancorp
Minnesota
$14K 1,500
Citigroup
79
Citigroup
New York
$7K 734 +134 +22%
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
$6K 662 +174 +36%
PMFA
81
Plante Moran Financial Advisors
Michigan
$3K 380
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
$2.9K 315 -184 -37%
Creative Planning
83
Creative Planning
Kansas
$2K 200 +200 New
SEI Investments
84
SEI Investments
Pennsylvania
$1K 132
Walleye Trading
85
Walleye Trading
New York
$42 4,600 -300 -6%
EAM
86
Eventide Asset Management
Massachusetts
-190,000 Closed
SCA
87
Secor Capital Advisors
New York
-26,380 Closed
PP
88
PDT Partners
New York
-23,900 Closed
Citadel Advisors
89
Citadel Advisors
Florida
-18,306 Closed
Wellington Management Group
90
Wellington Management Group
Massachusetts
-14,300 Closed
AIM
91
Acrospire Investment Management
Illinois
-13,122 Closed
SO
92
STRS Ohio
Ohio
-10,800 Closed
Group One Trading
93
Group One Trading
Illinois
-4,503 Closed
PCM
94
Prelude Capital Management
New York
-656 Closed
AG
95
Advisor Group
Arizona
-140 Closed
RFA
96
Reilly Financial Advisors
California
-100 Closed
BC
97
Broadfin Capital
New York